在治疗晚期肝细胞癌当前的影响:挑战仍然存在
Angelo A de Mattos1, Cristiane V Tovo1, Isadora Z Bombassaro1
1Department of Hepatology, Federal University of Health Sciences of Porto Alegre, Porto Alegre 90050-170, Rio Grande do Sul, Brazil.
World journal of gastrointestinal oncology
|March 17, 2025
概括
肝动脉输液化疗可能对晚期肝癌没有优势. 目前的证据缺乏严格性,新的治疗方法正在出现,限制了这种方法的使用.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 肝细胞癌 (HCC) 是全球主要的死亡原因,特别是在肝硬化患者中.
- 晚期诊断HCC往往是由于对肝硬化患者的监测被忽视,导致晚期检测.
研究的目的:
- 批判性地评估一个网络对晚期HCC肝动脉输液化疗 (HAIC) 的元分析的方法严谨性.
- 评估HAIC,跨动脉化学栓塞 (TACE) 和索拉芬尼布在先进的HCC治疗中的当前状况.
主要方法:
- 对网络元分析进行批评,调查HAIC与索拉芬尼和TACE对先进的HCC.
- 审查现有的治疗选择和新兴治疗方法,包括免疫检查点抑制剂.
主要成果:
- 据报道,引用的关于高级HCC的HAIC的元分析报告缺乏方法严格性,限制了最终的结论.
- 当适当指示时,超动脉化学栓塞 (TACE) 仍然有效.
- 由于免疫治疗的进步,索拉芬尼不再是推的高级HCC的第一线治疗方法.
结论:
- 晚期HCC肝动脉输液化疗 (HAIC) 的临床实用性和科学支持越来越可疑.
- 该研究强调需要有力的证据,并建议转向像免疫疗法这样的新疗法策略.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:27Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K